Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122


Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.

Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, Sun M, Nabi J, Nguyen PL, Hu JC, Kibel AS, Choueiri TK, Kluth LA, Trinh QD.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):125-136. doi: 10.1038/s41391-018-0083-4. Epub 2018 Aug 31.


Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.

Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H.

Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2.


Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.

Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu Z, Li S, Chen Q, Song Y, Gao S.

Cancer Med. 2017 Nov;6(11):2745-2756. doi: 10.1002/cam4.1220. Epub 2017 Oct 4.


Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

Schmid M, Meyer CP, Reznor G, Choueiri TK, Hanske J, Sammon JD, Abdollah F, Chun FK, Kibel AS, Tucker-Seeley RD, Kantoff PW, Lipsitz SR, Menon M, Nguyen PL, Trinh QD.

JAMA Oncol. 2016 Jan;2(1):85-93. doi: 10.1001/jamaoncol.2015.3384.


Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.

Schwartz K, Ruterbusch JJ, Colt JS, Miller DC, Chow WH, Purdue MP.

Cancer Med. 2016 Feb;5(2):200-8. doi: 10.1002/cam4.578. Epub 2015 Dec 29.


Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.

Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ.

Arch Surg. 2010 Dec;145(12):1158-63. doi: 10.1001/archsurg.2010.272.


Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?

Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, Nguyen PL, Lipsitz SR, Sun M, Choueiri TK, Preston MA, Kibel AS, Trinh QD.

Cancer. 2019 Apr 15;125(8):1319-1329. doi: 10.1002/cncr.31926. Epub 2019 Jan 11.


Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.

Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H.

Obstet Gynecol. 2015 Apr;125(4):833-42. doi: 10.1097/AOG.0000000000000643.


Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.

Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A.

Gastroenterology. 2018 Mar;154(4):906-915.e7. doi: 10.1053/j.gastro.2017.11.005. Epub 2017 Nov 14.


Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.

Hayn MH, Orom H, Shavers VL, Sanda MG, Glasgow M, Mohler JL, Underwood W 3rd.

Cancer. 2011 Oct 15;117(20):4651-8. doi: 10.1002/cncr.26103. Epub 2011 Mar 31.


Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis.

Dobbs RW, Malhotra NR, Abern MR, Moreira DM.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):159-167. doi: 10.1038/s41391-018-0097-y. Epub 2018 Oct 2.


Race, prostate cancer survival, and membership in a large health maintenance organization.

Robbins AS, Whittemore AS, Van Den Eeden SK.

J Natl Cancer Inst. 1998 Jul 1;90(13):986-90.


Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349. Epub 2015 May 11.


Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.

Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B.

JAMA. 1995 Nov 22-29;274(20):1599-605.


Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

White A, Coker AL, Du XL, Eggleston KS, Williams M.

Cancer. 2011 Mar 1;117(5):1080-8. doi: 10.1002/cncr.25671. Epub 2010 Nov 8.


Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW; ACCENT Collaborative Group.

J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. doi: 10.1093/jnci/djr310. Epub 2011 Oct 12.


Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.

Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL.

Ann Oncol. 2017 May 1;28(5):1098-1104. doi: 10.1093/annonc/mdx041.


Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.

Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM.

Cancer J. 2014 Jul-Aug;20(4):237-45. doi: 10.1097/PPO.0000000000000058.


Supplemental Content

Support Center